Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
Favipiravir has broad-spectrum antiviral activity against a variety of RNA viruses. Here the authors investigate the safety, pharmacokinetics and anti-SARS-CoV-2 efficacy of different drug dosage in the a Syrian hamster model of infection and, combined with genetic analyses, they show that Favipirav...
Guardado en:
Autores principales: | Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard, Jérémie Guedj, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28b65fe72e8643d09a5316e736cd7471 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
por: Franck Touret, et al.
Publicado: (2021) -
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
por: Ashleigh Shannon, et al.
Publicado: (2020) -
Favipiravir Inhibits Mayaro Virus Infection in Mice
por: Michèle Bengue, et al.
Publicado: (2021) -
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
por: Philippine Eloy, et al.
Publicado: (2021) -
A novel and sensitive real-time PCR system for universal detection of poxviruses
por: Léa Luciani, et al.
Publicado: (2021)